Partnership of Lifeforce and Toku Sets New Standards in Longevity and Cardiovascular Health Technology

Lifeforce and Toku Join Forces for Revolutionary Health Monitoring



In an innovative move, Lifeforce, the leading platform for longevity medicine, has teamed up with Toku, a health tech company that utilizes AI to convert retinal imagery into real-time biological age assessments and cardiovascular risk indicators. This partnership marks a significant advancement in proactive health assessments, transforming routine eye exams into vital opportunities for early health insights and interventions.

The collaboration combines Toku’s cutting-edge BioAge™ wellness product with their upcoming technology, CLAiR™. This impressive tool, which has received FDA Breakthrough Device designation, aims to enhance the non-invasive assessment of cardiovascular risks through retinal imaging coupled with artificial intelligence. CLAiR is currently on an expedited development route, with expectations for FDA approval in 2026, positioning it at the forefront of cardiovascular health technology.

Individuals who undergo a BioAge analysis will have their biological age compared to their chronological age, all derived from a simple retinal image. This analysis will seamlessly connect users to Lifeforce’s comprehensive longevity platform, which offers a wide array of services including at-home diagnostics, access to board-certified longevity physicians, personalized health protocols, and support from certified health coaches. This integrated approach empowers participants to make informed, data-driven decisions aimed at extending their healthspan.

Dugal Bain-Kim, the Co-Founder and CEO of Lifeforce, emphasized the transformative nature of this partnership, stating, "Seeing the risk is only half the job; taking action is what truly changes lives. Toku provides the earliest signals, while Lifeforce offers the clinician-guided programs designed to slow aging, mitigate cardiovascular risk, and ultimately enhance the health span of individuals."

Ehsan Vaghefi, PhD, CEO and Co-Founder of Toku, reiterated the importance of this partnership by noting, "By collaborating with Lifeforce, we ensure our users are not only equipped with health data but also receive support from a premier evidence-based longevity care team. Together, we are paving the way for a proactive and accessible approach to lifelong health and well-being."

About Lifeforce


Lifeforce stands as the largest platform dedicated to longevity medicine worldwide. Their mission is to empower adults to enrich the quality of their years through various means such as at-home biomarker testing, direct lines to expert physicians, tailored lifestyle coaching, and scientifically-backed treatment options. To date, thousands of members have completed over one million biomarker tests, with a remarkable 85% reporting improvements in health and quality of life within six months of engagement with the platform. More information can be found at www.mylifeforce.com.

About Toku


Toku, Inc. is a pioneering technology firm focused on developing non-invasive, AI-driven diagnostic tools that evaluate cardiovascular and systemic health risks via retinal imaging. Their flagship product, BioAge™, is available in the United States as a wellness tool to foster general health awareness. BioAge™ estimates biological age by analyzing retinal biometric markers. It's essential to clarify that BioAge is not designed for the diagnosis, treatment, or prevention of any diseases, nor is it classified as a medical device by the FDA. Toku is also advancing CLAiR™, a medical device platform that utilizes AI to evaluate cardiovascular risks from retinal images, although this device is yet to receive FDA approval in the United States. Toku's team comprises experts from various fields, all dedicated to making their innovative technology more accessible through strategic partnerships and clinical collaborations. For further insight, visit www.tokueyes.com.

Conclusion


The collaboration between Lifeforce and Toku signifies an important leap forward in medical technology, enabling individuals to not only gain insights into their health but also take actionable steps towards improvement. With the ability to assess health risks through easily accessible methods, this partnership is set to redefine how we approach health management and longevity in modern society.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.